Abstract
Background: Antenatal pulmonary inflammation is associated with reduced risk for respiratory distress syndrome but with an increased risk for bronchopulmonary dysplasia (BPD) with impaired alveogenesis. Objective: We hypothesized that fetal systemic inflammation induced by intravenous (IV) lipopolysaccharide (LPS) would affect lung development in utero. Study Design: Twenty-one fetal sheep were instrumented (107 days gestational age). Control fetuses received saline (N = 12) and 9 in the study group received 100 ng of LPS IV 3 days after surgery. Animals were assessed for lung maturation and structure after 3 (N = 5) and 7 (N = 4) days. Results: Interleukin-6 concentration increased in the bronchoalveolar lavage more than 40-fold 3 days after LPS IV. Processing of pro-surfactant protein (SP)-B to mature SP-B and increased SP-B concentrations were shown 7 days after LPS IV. Deposition of elastin fibers at sites of septation was disturbed within 3 days after LPS IV. Conclusion: Lung maturation and disturbed lung structure occurred after short-term exposure to fetal inflammation and suggests new targeted therapies for BPD.
Original language | English |
---|---|
Pages (from-to) | 195.e1-195.e10 |
Journal | American Journal of Obstetrics and Gynecology |
Volume | 200 |
Issue number | 2 |
DOIs | |
Publication status | Published - Feb 2008 |
Externally published | Yes |
Bibliographical note
Funding Information:Supported by the Interdisciplinary Center for Clinical Research, Wuerzburg, Germany, Grant A-27; the Universitätsbund Würzburg, the Schuster Stiftung, Frankfurt a.M., Germany; and the Stichting Kindergeneeskunde, and Research School GROW, University of Maastricht, Maastricht, the Netherlands.